Neurocrine Biosciences earnings (net income)
Neurocrine Biosciences (NBIX) earned a net income of $478.60 M in fiscal year 2025, +40.2% compared with the year before. Net profit margin: 16.7% of revenue.
Earnings 2025$478.60 M
Change+40.2%
World rank#844
Market cap$15.85 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $478.60 M | +40.2% |
| 2024 | $341.30 M | +36.7% |
| 2023 | $249.70 M | +61.6% |
| 2022 | $154.50 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.